670224474 | PUO | 57155429 | | 1748541 | 3/10/2005 12:00:00 AM | OA , L knee | | DIS | Admission Date: 8/21/2005 Report Status:

Discharge Date: 8/13/2005
****** FINAL DISCHARGE ORDERS ******
SMOLINSKY , LARAE 070-17-73-5
S Wi Ester O Coing
Service: ORT
DISCHARGE PATIENT ON: 10/7/05 AT 11:00 AM
CONTINGENT UPON PT clearance
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: FANIEL , GAYLENE , M.D.
DISPOSITION: Home w/ services
DISCHARGE MEDICATIONS:
ALLOPURINOL 300 MG PO QD
Alert overridden: Override added on 2/4/05 by
WANTUCK , DELPHA , PA-C
SERIOUS INTERACTION: WARFARIN &amp; ALLOPURINOL
Reason for override: will monitor
CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO QD
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
FERROUS SULFATE 325 MG PO TID
Food/Drug Interaction Instruction Avoid milk and antacid
HUMULIN N ( INSULIN NPH HUMAN ) 15 UNITS SC QAM and QPM
MVI ( MULTIVITAMINS ) 1 TAB PO QD
Override Notice: Override added on 2/4/05 by
WANTUCK , DELPHA , PA-C
on order for SIMVASTATIN PO ( ref # 46213778 )
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp;
SIMVASTATIN Reason for override: will be monitored
OXYCODONE 5-10 MG PO Q4H PRN Pain
METAMUCIL SUGAR FREE ( PSYLLIUM ( METAMUCIL ) SU... )
1 PACKET PO QD PRN Constipation
Instructions: may be given with the patients choice of
beverage
COUMADIN ( WARFARIN SODIUM ) 4 MG PO QPM
Starting ROUTINE , 20:00 ( Standard Admin Time )
Instructions: dose for 7/2/05 4mg , dose for 4/12 and
thereafter take as directed by anticoagulation
service , duration is 4 weeks
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Reason: Override added on 2/4/05 by WANTUCK , DELPHA , PA-C
on order for SIMVASTATIN PO ( ref # 46213778 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; SIMVASTATIN
Reason for override: will be monitored
Previous override information:
Override added on 2/4/05 by WANTUCK , DELPHA , PA-C
on order for ALLOPURINOL PO ( ref # 41656086 )
SERIOUS INTERACTION: WARFARIN &amp; ALLOPURINOL
Reason for override: will monitor
NORVASC ( AMLODIPINE ) 10 MG PO QD
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
METFORMIN 500 MG PO BID
LIPITOR ( ATORVASTATIN ) 20.0 MG PO QD
Alert overridden: Override added on 6/14/05 by :
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp;
ATORVASTATIN CALCIUM
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; ATORVASTATIN
CALCIUM Reason for override: will be monitored
IRON SULFATE ( FERROUS SULFATE ) 325 MG PO QD
Food/Drug Interaction Instruction Avoid milk and antacid
DIET: House / ADA 2100 cals/dy
ACTIVITY: Full weight-bearing: please increase ROM as much as possible
FOLLOW UP APPOINTMENT( S ):
Dr. Rademan , 2/20/05 1:00XRAY , 2:00APT scheduled ,
Arrange INR to be drawn on 7/14/05 with f/u INR's to be drawn every
Monday/Thursday days. INR's will be followed by PUO Anticoagulation service , 592.004.9708
ALLERGY: LATEX
ADMIT DIAGNOSIS:
OA , L knee
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
OA , L knee
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
diabetes mellitus , hypertension , gout , atopic dermatitis
OPERATIONS AND PROCEDURES:
2/4/05 RADEMAN , CAITLIN , M.D.
RT TKR
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
9/1/05-KUB-negative
BRIEF RESUME OF HOSPITAL COURSE:
***Patient underwent elective LTKA for osteoarthritis on 2/4/05 .
Procedure went well and pain was controlled by epidural. Patient
received 1 unit of RBC's on DOS for HCT of 26. POD2 patient had a
distended abdomen and KUB was ordered. Results were negative and there
were no further signs of symptoms of an ileus. POD2
switched to oral pain meds and foley catheter removed. HCT on POD3 was
25.8 and patient was stable. Patient could not clear PT protocol for
discharge on POD4 and subsequently was not dischrarged until POD5 in
stable condition. On POD#5 after two days of IV fluid his creatinine
improved to 1/3. His INR on the day of discharge was 1.5.
ADDITIONAL COMMENTS: Coumadin for DVT prophylaxis X3 weeks. Goal INR 1.5-2.5 , draw day after
discharge and every Monday/Thursday. Results &amp; questions to PUO
Anticoagulation service , 083.782.7650. For wound-DSD changes , OTA when
dry. Remove staples on 8/21/05 .  Follow up with Dr. Rademan on 2/20/05 .
Weight bear as tolerated with upper extemity support.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
Home care for blood draws-results and questions to PUO Anticoagulation
service , 083.782.7650. See instructions for complete detail.
Home care for wound-DSD changes , OTA when dry , remove sutures on
8/21/05 .
PT-weight bear as tolerated with upper extremity support.
Follow up with Dr. Rademan on 2/20/05 .
No dictated summary
ENTERED BY: DEMOREST , MEGHAN O , M.D. ( PI820 ) 10/7/05 @ 02:38 PM
****** END OF DISCHARGE ORDERS ******